Sign In

Anthony Magliocco MD

President and CEO at Protean BioDiagnostics Inc

Dr. Anthony Magliocco is the President and CEO of Protean Biodiagnostics, a company dedicated to providing advanced diagnostic tools for personalized cancer treatment.

With a background in medicine, specifically a Doctor of Medicine (MD) from the University of Alberta, and a Bachelor of Science (BSc) in Biological Sciences from The University of Lethbridge, Dr. Magliocco is an expert in pathology and precision oncology.

Prior to his current role, Dr. Magliocco held various positions including Professor of Pathology at the University of Central Florida, Founder, President, and CEO of Protean Biodiagnostics Inc, and leadership roles at the Moffitt Cancer Center and the Canadian Breast Cancer Foundation Tumor Bank.

His extensive experience encompasses chair positions, directorship, and scientific roles in organizations such as RTOG (Radiation Therapy Oncology Group), Tom Baker Cancer Centre, and the University of Calgary, where he also served as a Professor of Oncology, Pathology, and Laboratory Medicine.

Dr. Magliocco's vision for Protean Biodiagnostics revolves around integrating advanced diagnostics into cancer care to enhance treatment outcomes and pave the way for a future where tailored therapies are standard for all cancer patients.

Anthony Magliocco MD
Add to my network

Location

Orlando, Florida, United States